# Chloroquine (CQ) and Azithromycin (AZ) Combination for Malaria Prophylaxis

> **NCT03278808** · PHASE2 · WITHDRAWN · sponsor: **U.S. Army Medical Research and Development Command**

## Conditions studied

- Malaria

## Interventions

- **DRUG:** Chloroquine-Azithromycin (CQ/AZ)
- **DRUG:** Chloroquine (CQ)
- **DRUG:** atovaquone-proguanil (Malarone®)

## Key facts

- **NCT ID:** NCT03278808
- **Lead sponsor:** U.S. Army Medical Research and Development Command
- **Sponsor class:** FED
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2018-09-17
- **Primary completion:** 2019-12-30
- **Final completion:** 2020-01-01
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** The IND has been withdrawn from FDA
- **Last updated:** 2020-02-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03278808

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03278808, "Chloroquine (CQ) and Azithromycin (AZ) Combination for Malaria Prophylaxis". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT03278808. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*